Tentative agenda of 2016 Annual General Meeting of Shareholders Of Baoviet Holdings

Meeting Summary October 2-4, 2010 – Washington, D.C. Review of the 25th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer (now the Society for Immunotherapy of Cancer) Interaction • Innovation • Integration • Exchange • Translation • Leadership Guiding cancer immunotherapy from bench to bedside Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer Balwit et al. Balwit et al. Journal of Translational Medicine 2011, 9:60 http://www.translational-medicine.com/content/9/1/60 (12 May 2011) MEETI N G REP O R T Open Access Review of the 25 th annual scientific meeting of the International Society for Biological Therapy of Cancer James M Balwit 1 , Pawel Kalinski 2 , Vernon K Sondak 3 , Pierre G Coulie 4 , Elizabeth M Jaffee 5 , Thomas F Gajewski 1,6 and Francesco M Marincola 1,7* Abstract Led by key opinion leaders in the field, the 25th Annual Meeting of the International Society for Biological Therapy of Cancer (iSBTc, recently renamed the Society for Immunotherapy of Cancer, SITC) provided a scientific platform for ~500 attendees to exchange cutting-edge information on basic, clinical, and translational research in cancer immunology and immunotherapy. The meeting included keynote addresses on checkpoint blockade in cancer therapy and recent advances in therapeutic vaccination against cancer induced by Human Papilloma Virus 16. Participants from 29 countries interacted through oral presentations, panel discussions, and posters on topics that included dendritic cells and cancer, targeted therapeutics and immunotherapy, innate/adaptive immune interplay in cancer, clinical trial endpoints, vaccine combinations, countering negative regulation, immune cell trafficking to tumor microenvironment, and adoptive T cell transfer. In addition to the 50 oral presentations and >180 posters on these topics, a new SITC/iSBTc initiative to create evidence-based Cancer Immunotherapy Guidelines was announced. The SITC/iSBTc Biomarkers Taskforce announced the release of recommendations on immunotherapy biomarkers and a highly successful symposium on Immuno-Oncology Biomarkers that took place on the campus of the National Institutes of Health (NIH) immediately prior to the Annual Meeting. At the Annual Meeting, the NIH took the opportunity to publicly announce the award of the U01 grant that will fund the Cancer Immunotherapy Trials Network (CITN). In summa ry, the Annual Meeting gathered clinicians and scientists from academia, industry, and regulatory agencies from around the globe to interact and exchange important scientific advances related to tumor immunobiology and cancer immunotherapy. Guiding Cancer Immunotherapy from Bench to Bedside The opening scientific presentation–the Richard V. Smalley, MD Memorial Lectureship–was delivered by James P. Allison, PhD (Memorial Sloan-Kettering Can- cer Center), a pioneer in the development of CTLA-4 blockade. Dr. Allison presented data on new insights and opportunities in checkpoint blockade. He outlined a number of key points to be addressed for further clinical development of TENTATIVE AGENDA OF 2016 Annual General Meeting of Shareholders Of Baoviet Holdings Time Venue : From 08:00am, Wednesday May 18th 2016 : Melia Hotel – No 44B Ly Thuong Kiet Str., Hoan Kiem District, Hanoi No Time Content Person in charge 08:00 – 08:15 Welcome and registration for 2016 Annual General Meeting of Shareholders (AGM) Shareholders’ eligibility inspecting division 08:15 – 08:25 Flag salutation and Opening session The Meeting Organizer 08:25 – 08:30 Report the result of inspecting Shareholders’ eligibility & the validity of the Meeting Shareholders’ eligibility inspecting division Introduction & approval: 08:30 – 08:40 + Regulation on organizing 2016 AGM; + Members of Chairing Board; - Introduction of Secretary Board - Introduction & approval: Voting and Election Board Introduction & approval: Agenda of 2016 AGM Content 1: Report of the Board of Directors (BOD) 08:40 08:40 – 08:45 08:45 – 09:00 09:00 – 09:20 Content 2: Report on 2015 business performance and 2016 business plan 09:20 – 09:30 Content 3: Report of the Supervisory Board 10 09:30 – 09:40 Content 4: Submission for approval of Charter of Baoviet Holdings (the 7th amendment and supplement) 09:40 – 09:50 Content 5: Submission for approval of 2015 audited consolidated and seperate financial statements of Baoviet Holdings 12 09:50 – 10:00 Content 6: Submission for approval of remuneration for BOD and Supervisory board in 2015 and proposed remuneration in 2016 13 10:00 – 10:10 Content 7: Submission on allocation of PAT in 2015 fiscal year and using plan of PAT in 2016 fiscal year 14 10:10 – 10:20 Content 8: 11 The Meeting Organizer Chairing Board Chairing Board Chairman of the BOD CEO Head of Supervisory Board BOD’s member Deputy Chief Financial Officer BOD’s member BOD’s member No Time 17 10:50 – 11:00 Content Submission on the orientation of development strategy for the period of 2016 – 2020 of Baoviet Financial – Insurance Group Content 9: Submission on the report of the implementation of charter capital increase by private placement according to Resolution No 02/2016/TĐBVĐHĐCĐ of the 2014 AGM Content 10: - Submission for approval of the replacement of two BODs’members - Shareholders discuss and vote for approval of elections and voting methods - Head of Election Board approves election regulation and instructs voting procedure - Shareholders vote Tea-break + Vote counting 15 10:20 – 10:30 18 11:00 – 11:10 Content 11 (if any) BOD’s member Election Board 11:10 – 11:40 - Announce the election results of supplement and replacement of BODs’ members according to content 10 - Shareholders discuss and vote for content to 11 16 19 10:30 – 10:50 20 11:40 – 11:55 Approve the Minutes and Resolution of 2016 AGM 21 11:55 – 12:00 Closing session Person in charge Chairman of the BOD BOD’s member BOD’s member Election Board Chairing Board Secretary Board The Meeting Organizer ... Submission on the orientation of development strategy for the period of 2016 – 2020 of Baoviet Financial – Insurance Group Content 9: Submission on the report of the implementation of charter capital increase... to Resolution No 02 /2016/ TĐBVĐHĐCĐ of the 2014 AGM Content 10: - Submission for approval of the replacement of two BODs’members - Shareholders discuss and vote for approval of elections and voting... Minutes and Resolution of 2016 AGM 21 11:55 – 12:00 Closing session Person in charge Chairman of the BOD BOD’s member BOD’s member Election Board Chairing Board Secretary Board The Meeting Organizer